STAMBP
Basic information
Region (hg38): 2:73828916-73873659
Links
Phenotypes
GenCC
Source:
- microcephaly-capillary malformation syndrome (Definitive), mode of inheritance: AR
- microcephaly-capillary malformation syndrome (Strong), mode of inheritance: AR
- microcephaly-capillary malformation syndrome (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Microcephaly-capillary malformation syndrome | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Dermatologic; Neurologic | 23542699 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (7 variants)
- Microcephaly-capillary malformation syndrome (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STAMBP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 26 | 31 | ||||
missense | 73 | 82 | ||||
nonsense | 6 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 3 | 4 | 6 | 1 | 14 | |
non coding | 27 | 18 | 45 | |||
Total | 11 | 9 | 76 | 56 | 21 |
Highest pathogenic variant AF is 0.0000329
Variants in STAMBP
This is a list of pathogenic ClinVar variants found in the STAMBP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-73830569-C-T | Likely benign (Mar 03, 2019) | |||
2-73830859-G-GTC | Microcephaly-capillary malformation syndrome | Pathogenic (Oct 03, 2023) | ||
2-73830868-T-A | Uncertain significance (Aug 23, 2022) | |||
2-73830868-T-C | not specified • Microcephaly-capillary malformation syndrome | Benign (Feb 01, 2024) | ||
2-73830870-G-A | Uncertain significance (Dec 02, 2021) | |||
2-73830885-C-T | Uncertain significance (Oct 24, 2022) | |||
2-73830888-C-T | Uncertain significance (Feb 16, 2023) | |||
2-73830889-C-T | Microcephaly-capillary malformation syndrome • STAMBP-related disorder | Likely benign (Jan 18, 2024) | ||
2-73830890-G-A | Uncertain significance (Jul 19, 2022) | |||
2-73830897-G-A | Uncertain significance (Dec 03, 2021) | |||
2-73830905-G-C | Uncertain significance (Jun 05, 2022) | |||
2-73830915-A-G | Uncertain significance (Aug 17, 2023) | |||
2-73830923-A-G | Uncertain significance (Dec 29, 2021) | |||
2-73830927-C-T | Inborn genetic diseases | Uncertain significance (Dec 07, 2023) | ||
2-73830928-G-A | STAMBP-related disorder | Likely benign (Jul 03, 2022) | ||
2-73830939-A-G | Uncertain significance (Nov 08, 2022) | |||
2-73830943-A-C | Uncertain significance (Dec 03, 2021) | |||
2-73830956-C-T | Uncertain significance (Jul 19, 2022) | |||
2-73830960-G-A | Inborn genetic diseases | Uncertain significance (May 23, 2024) | ||
2-73830962-TAC-AA | Pathogenic (Mar 14, 2016) | |||
2-73830968-C-G | Microcephaly-capillary malformation syndrome | Uncertain significance (Jun 07, 2022) | ||
2-73830968-C-T | Microcephaly-capillary malformation syndrome | Pathogenic/Likely pathogenic (Jun 26, 2023) | ||
2-73830969-G-A | Microcephaly-capillary malformation syndrome | Uncertain significance (Apr 04, 2024) | ||
2-73830981-A-G | Microcephaly-capillary malformation syndrome | Likely pathogenic (Jun 15, 2023) | ||
2-73831027-A-G | Likely benign (Oct 22, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STAMBP | protein_coding | protein_coding | ENST00000394070 | 9 | 44701 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000545 | 0.994 | 125717 | 0 | 30 | 125747 | 0.000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.886 | 202 | 241 | 0.839 | 0.0000131 | 2774 |
Missense in Polyphen | 62 | 92.642 | 0.66924 | 1034 | ||
Synonymous | -0.0341 | 91 | 90.6 | 1.00 | 0.00000484 | 824 |
Loss of Function | 2.43 | 11 | 23.8 | 0.462 | 0.00000144 | 263 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000516 | 0.000514 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000115 | 0.000114 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000133 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Zinc metalloprotease that specifically cleaves 'Lys-63'- linked polyubiquitin chains. Does not cleave 'Lys-48'-linked polyubiquitin chains (By similarity). Plays a role in signal transduction for cell growth and MYC induction mediated by IL-2 and GM-CSF. Potentiates BMP (bone morphogenetic protein) signaling by antagonizing the inhibitory action of SMAD6 and SMAD7. Has a key role in regulation of cell surface receptor-mediated endocytosis and ubiquitin-dependent sorting of receptors to lysosomes. Endosomal localization of STAMBP is required for efficient EGFR degradation but not for its internalization (By similarity). Involved in the negative regulation of PI3K-AKT-mTOR and RAS-MAP signaling pathways. {ECO:0000250, ECO:0000269|PubMed:10383417, ECO:0000269|PubMed:11483516, ECO:0000269|PubMed:15314065, ECO:0000269|PubMed:17261583, ECO:0000269|PubMed:23542699}.;
- Disease
- DISEASE: Microcephaly-capillary malformation syndrome (MICCAP) [MIM:614261]: A congenital disorder characterized by severe progressive microcephaly, early-onset refractory epilepsy, profound developmental delay, and multiple small capillary malformations spread diffusely on the body. Additional more variable features include dysmorphic facial features, distal limb abnormalities, and mild heart defects. {ECO:0000269|PubMed:23542699}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Endocytosis - Homo sapiens (human);EGF-EGFR Signaling Pathway;Post-translational protein modification;Metabolism of proteins;Metalloprotease DUBs;EGFR1;Deubiquitination;Internalization of ErbB1
(Consensus)
Recessive Scores
- pRec
- 0.129
Intolerance Scores
- loftool
- 0.837
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 57.15
Haploinsufficiency Scores
- pHI
- 0.199
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.578
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.850
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Stambp
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype;
Gene ontology
- Biological process
- mitotic cytokinesis;JAK-STAT cascade;positive regulation of cell population proliferation;negative regulation of phosphatidylinositol 3-kinase signaling;protein deubiquitination;negative regulation of neuron apoptotic process;negative regulation of Ras protein signal transduction;protein K63-linked deubiquitination
- Cellular component
- nucleus;nucleoplasm;endosome;early endosome;cytosol;plasma membrane;membrane;cleavage furrow;extracellular exosome
- Molecular function
- thiol-dependent ubiquitin-specific protease activity;protein binding;metallopeptidase activity;protein domain specific binding;metal ion binding;Lys63-specific deubiquitinase activity